Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of MORAb-003 in Subjects With Advanced Ovarian Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating safety, tolerability and pharmacokinetics of MORAb-003 (farletuzumab) in patients with advanced ovarian cancer reports the initial sa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• MORAb-003 (farletuzumab)

Snippet

Sponsor: Morphotek | Conditions: Epithelial Ovarian Cancer | Phase 1 | Status: COMPLETED